Conference Reports for NATAP
51th ICAAC
Chicago, IL
September 17-20, 2011
Back
ART-HCV Protease Inhibitor BI-201335 Interactions
BI 201335 HCV Protease in Coinfection Study ARTs Allowed in Study - ART Drug-Drug Interactions
In a slide presentation by Juergen Rockstroh at HCV Symposium at ICAAC:
